Perini MV, Starkey G, Fink MA, Bhandari R, Muralidharan V, Jones R, Christophi C. From minimal to maximal surgery in the treatment of hepatocarcinoma: A review. World J Hepatol 2015; 7(1): 93-100 [PMID: 25625000 DOI: 10.4254/wjh.v7.i1.93]
Corresponding Author of This Article
Marcos Vinicius Perini, MD, PhD, Austin Health, Department of Surgery, University of Melbourne, 145 Studley Road, Level 8, Heidelberg, VIC 3084, Australia. marcos.perini@unimelb.edu.au
Research Domain of This Article
Surgery
Article-Type of This Article
Topic Highlight
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Perini MV, Starkey G, Fink MA, Bhandari R, Muralidharan V, Jones R, Christophi C. From minimal to maximal surgery in the treatment of hepatocarcinoma: A review. World J Hepatol 2015; 7(1): 93-100 [PMID: 25625000 DOI: 10.4254/wjh.v7.i1.93]
World J Hepatol. Jan 27, 2015; 7(1): 93-100 Published online Jan 27, 2015. doi: 10.4254/wjh.v7.i1.93
From minimal to maximal surgery in the treatment of hepatocarcinoma: A review
Marcos Vinicius Perini, Graham Starkey, Michael A Fink, Ramesh Bhandari, Vijayaragavan Muralidharan, Robert Jones, Christopher Christophi
Marcos Vinicius Perini, Graham Starkey, Michael A Fink, Ramesh Bhandari, Vijayaragavan Muralidharan, Robert Jones, Christopher Christophi, Austin Health, Department of Surgery, University of Melbourne, Heidelberg, VIC 3084, Australia
Author contributions: Perini MV designed the review, collected data, wrote the manuscript; Starkey G reviewed the manuscript; Fink MA, Bhandari R, Muralidharan V, Jones R and Christophi C reviewed the manuscript.
Correspondence to: Marcos Vinicius Perini, MD, PhD, Austin Health, Department of Surgery, University of Melbourne, 145 Studley Road, Level 8, Heidelberg, VIC 3084, Australia. marcos.perini@unimelb.edu.au
Telephone: +61-422-493101 Fax: +61-394-963670
Received: September 11, 2014 Peer-review started: September 13, 2014 First decision: October 14, 2014 Revised: October 28, 2014 Accepted: November 17, 2014 Article in press: November 19, 2014 Published online: January 27, 2015 Processing time: 121 Days and 0.7 Hours
Core Tip
Core tip: The decision making approach to the cirrhotic patient with hepatocellular carcinoma (HCC) represents one of the most challenging frontiers in liver surgery and, as a result, should involve a multidisciplinary assessment. Despite the advances in non-surgical therapies, surgery is still the treatment that can offer the best survival. In patients submitted to liver resection who experience recurrence, re-resection or salvage liver transplantation has been shown to be an alternative approach in well-selected cases. We herein discuss some controversial topics regarding the surgical treatment of HCC: anatomical resection, margin status, macro-vascular invasion, laparoscopic resection, salvage liver transplantation and liver transplantation.
